Business Description
vTv Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US9183851057
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.86 | |||||
Equity-to-Asset | -2.24 | |||||
Debt-to-Equity | -0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -6.7 | |||||
3-Year EPS without NRI Growth Rate | -10.5 | |||||
3-Year FCF Growth Rate | 15.7 | |||||
3-Year Book Growth Rate | 41.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 25.72 | |||||
14-Day RSI | 29.27 | |||||
6-1 Month Momentum % | -23.2 | |||||
12-1 Month Momentum % | -58.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.6 | |||||
Shareholder Yield % | 0.32 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -91.68 | |||||
ROIC % | -324.57 | |||||
ROC (Joel Greenblatt) % | -5644.41 | |||||
ROCE % | -202.71 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.04 | |||||
EV-to-EBITDA | -2.04 | |||||
EV-to-Forward-Revenue | 25.88 | |||||
EV-to-FCF | -2.72 | |||||
Earnings Yield (Greenblatt) % | -49.02 | |||||
FCF Yield % | -30.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
vTv Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -9.025 | ||
Beta | -0.57 | ||
Volatility % | 38.55 | ||
14-Day RSI | 29.27 | ||
14-Day ATR (€) | 0.000149 | ||
20-Day SMA (€) | 11.12 | ||
12-1 Month Momentum % | -58.2 | ||
52-Week Range (€) | 11.12 - 34.4 | ||
Shares Outstanding (Mil) | 2.43 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
vTv Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
vTv Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
vTv Therapeutics Inc Frequently Asked Questions
What is vTv Therapeutics Inc(FRA:5VT0)'s stock price today?
When is next earnings date of vTv Therapeutics Inc(FRA:5VT0)?
Does vTv Therapeutics Inc(FRA:5VT0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |